Biotechnology Remote Patient Monitoring Law In Russia.
1. Introduction
Biotechnology Remote Patient Monitoring (RPM) Law in Russia concerns the legal regulation of technologies used to monitor a patient's health remotely through digital medical devices, wearable sensors, connected diagnostic equipment, mobile applications, artificial intelligence (AI), and electronic health platforms.
Remote Patient Monitoring enables healthcare professionals to collect and evaluate patient information without requiring the patient to attend a medical facility for every examination.
Examples include:
Remote monitoring of blood pressure and heart rate.
Continuous glucose monitoring for diabetic patients.
Wearable ECG and cardiac monitoring devices.
Remote monitoring of oxygen saturation and respiratory conditions.
Digital monitoring of patients undergoing biotechnology-based treatments.
AI-assisted analysis of laboratory and physiological information.
Remote monitoring following surgery, transplantation, or regenerative medicine procedures.
In Russia, RPM does not operate under one comprehensive standalone statute. It is governed by a combination of healthcare legislation, telemedicine regulations, personal-data protection, medical-device regulation, clinical safety requirements, and civil liability principles.
The central legal issue is balancing technological innovation and patient access with medical supervision, confidentiality, clinical responsibility, and protection against inaccurate digital diagnoses.
2. Principal legislative framework
The principal legislation includes the following:
| Legislation | Legal significance |
|---|---|
| Federal Law No. 323-FZ of 21 November 2011 | Main healthcare legislation; Article 36.2 governs telemedicine and remote patient monitoring. |
| Federal Law No. 152-FZ of 27 July 2006 | Protection of personal data, including health-related information. |
| Federal Law No. 61-FZ of 12 April 2010 | Regulation of medicinal products and pharmaceutical safety. |
| Federal Law No. 258-FZ of 31 July 2020 | Experimental legal regimes for digital innovation. |
| Federal Law No. 63-FZ of 6 April 2011 | Electronic signatures and legally recognised electronic documents. |
| Federal Law No. 149-FZ of 27 July 2006 | Information, information technologies and information protection. |
An especially important development is Ministry of Health Order No. 193n of 11 April 2025, which replaced the earlier Order No. 965n from 1 September 2025. It establishes the updated procedure for organising and providing medical care using telemedicine technologies and remains in force until 1 September 2031.
ГАРАНТ+1
3. Article 36.2 of Federal Law No. 323-FZ: The central provision
Article 36.2 is the most important legal foundation for remote patient monitoring in Russia.
It recognises the use of telemedicine technologies for:
Preventive healthcare.
Collection and analysis of patient complaints.
Evaluation of medical history.
Assessment of the effectiveness of treatment.
Medical observation of a patient's health.
Determining whether an in-person examination is necessary.
The legal requirement for remote monitoring
Under Article 36.2(4), remote monitoring must generally be prescribed by the treating physician after an in-person appointment, examination or consultation.
Monitoring may rely on:
Data collected by medical devices designed to monitor the human body.
Information recorded in the Unified State Health Information System (EGISZ).
Regional state healthcare information systems.
Medical information systems.
Other qualifying information systems recognised by the legislation.
This provision is particularly important for biotechnology companies developing connected glucose monitors, cardiac sensors, wearable diagnostic devices and other digital medical technologies.
Consultant Plus+1
Legal interpretation: A technology company cannot automatically treat the collection of physiological information as an independent medical service. Where the activity constitutes regulated medical care, the statutory requirements governing medical supervision and telemedicine must be respected.
4. Licensing and regulatory requirements
Remote patient monitoring may involve several regulated activities.
A. Medical-service licensing
Where a company provides medical services, it must comply with Russian medical licensing legislation, including Government Resolution No. 852 of 1 June 2021 on licensing medical activities.
A company providing only technical infrastructure may have a different regulatory position from a company employing doctors to interpret patient results and make clinical decisions.
B. Medical-device registration
Remote monitoring equipment may qualify as medical devices under Article 38 of Federal Law No. 323-FZ.
Examples include:
ECG monitoring systems.
Continuous glucose monitoring devices.
Digital blood-pressure monitors intended for medical use.
Implantable monitoring devices.
Diagnostic software.
AI-supported clinical decision systems.
The legal classification depends on the device's intended medical purpose and functionality. A general-purpose smartwatch is not automatically equivalent to a registered medical device.
C. Software and artificial intelligence
Software that performs medical diagnostic or monitoring functions may itself qualify as a medical device.
Under the updated telemedicine framework, registered medical-device software incorporating AI may be used as a clinical decision-support system in relevant consultations.
The existence of an AI recommendation does not automatically transfer the treating physician's professional responsibility to the software developer.
ГАРАНТ+1
5. Patient consent and confidentiality
Remote monitoring produces particularly sensitive information, including:
Blood glucose readings.
Heart-rate patterns.
Genetic and genomic information.
Medication histories.
Biometric information.
Reproductive health information.
Long-term physiological records.
Article 13 of Federal Law No. 323-FZ protects medical confidentiality, while Federal Law No. 152-FZ regulates personal-data processing.
Healthcare organisations must establish lawful grounds for collecting, processing, storing and transmitting patient information.
Important compliance requirements include:
Providing appropriate information about the monitoring process.
Establishing the legal basis for processing personal data.
Restricting access to authorised personnel.
Protecting information against unauthorised disclosure.
Implementing appropriate cybersecurity safeguards.
Maintaining legally required medical records.
Complying with applicable Russian data-localisation requirements.
The rules governing special categories of personal data are particularly important because health information receives enhanced legal protection.
Cross-border data transfers: Where patient monitoring information is transmitted to foreign cloud providers, research institutions or biotechnology partners, the organisation must assess the additional requirements of Article 12 of Federal Law No. 152-FZ. Foreign hosting cannot simply be assumed to be permissible.
6. Electronic identification and medical documentation
Article 36.2 establishes two important safeguards.
A. Patient identification
The Unified System of Identification and Authentication (ESIA) is used for identification and authentication of participants in remote medical interactions, subject to applicable exceptions for qualifying experimental legal regimes.
B. Electronic medical records
Medical information generated during telemedicine care must be documented, including in the patient's medical records. Article 36.2(7) requires the use of an enhanced qualified electronic signature (УКЭП) by the medical professional.
This creates an evidentiary record of:
Monitoring results.
Medical consultations.
Clinical observations.
Treatment adjustments.
Physician decisions.
Medical recommendations.
Consultant Plus+1
7. Clinical negligence and professional liability
Remote monitoring creates new forms of potential medical negligence.
For example, liability may arise where:
A physician ignores an abnormal ECG reading.
A hospital fails to respond to dangerous glucose measurements.
A monitoring platform incorrectly classifies a patient's condition.
A medical organisation fails to arrange an examination when necessary.
A physician relies exclusively on unreliable sensor readings.
A hospital fails to establish a procedure for responding to emergency alerts.
Article 98 of Federal Law No. 323-FZ establishes liability in the healthcare sector for harm caused through the provision of medical care.
Other potentially applicable legislation includes:
Articles 1064 and 1068 of the Civil Code of Russia: general liability for harm and liability of employers for employees.
Article 1095 of the Civil Code: liability for harm caused by defects in goods, work or services.
Article 151 of the Civil Code: compensation for moral damage.
Article 14 of the Consumer Protection Law No. 2300-1, where consumer-protection rules apply.
The central question is whether the medical organisation, healthcare professional or other responsible party failed to meet the applicable standard of care and whether that failure caused legally recoverable harm.
8. Important Russian judicial decisions and case laws
There is an important distinction in this area: Russian judicial decisions specifically addressing continuous remote patient monitoring are relatively limited. Therefore, the following cases provide relevant telemedicine and medical-liability principles rather than a comprehensive body of direct RPM precedents.
Case 1: Ninth Cassation Court of General Jurisdiction, 6 February 2025
Direct telemedicine precedent
Case No. 8Г-12682/2024 (88-819/2025).
Facts:
A child's parent challenged the manner in which an online consultation concerning the child's endocrine treatment had been conducted.
The parent had requested a doctor–patient telemedicine consultation. However, the medical consultation took place in a doctor–doctor format.
The dispute concerned the consultation procedure, the parent's participation and the accuracy of the medical consultation record.
Judicial decision:
The cassation court upheld the lower courts' conclusions rejecting the claims for invalidation of the consultation protocol and compensation for moral damage.
The courts considered the circumstances of the consultation, its organisation, the applicable telemedicine rules and the medical documentation.
Legal principles:
Different telemedicine consultation formats have different procedural requirements.
A doctor–doctor consultation is not automatically unlawful merely because the patient or representative is absent.
The medical record must be assessed against the actual circumstances of the consultation.
A patient's disagreement with the consultation format does not, by itself, establish medical negligence.
Relevance to RPM: This decision is useful when determining whether remote monitoring information can be discussed between medical professionals without the patient's direct participation in every professional consultation.
ГАРАНТ
Case 2: Balashikha City Court, 2018
Case No. 2-168/2018.
Facts:
The case concerned the legality of telemedicine-related medical activities and the regulatory position following the introduction of Article 36.2 of Federal Law No. 323-FZ.
The dispute involved allegations concerning the organisation and legality of telemedicine activity.
Judicial approach:
The court examined the relevant healthcare legislation and the development of telemedicine regulation.
The court did not find sufficient grounds to grant the claims.
Legal principles:
Telemedicine is a legally recognised form of healthcare activity.
Medical and technical personnel must respect the applicable rules governing teleconsultations.
The legality of remote medical activity must be assessed through the applicable statutory framework.
Relevance to RPM: The case provides historical judicial context for the recognition of remote medical technologies in Russia. It should not be treated as a decision specifically approving every form of automated patient monitoring.
nami-rf.ru
Case 3: Eighth Cassation Court of General Jurisdiction, 10 September 2026
Case No. 8Г-14517/2026 (88-14879/2026).
Medical liability precedent
Facts and legal issue:
The dispute concerned compensation for moral damage arising from allegedly inadequate medical assistance.
The court considered the standards for assessing the quality of medical examination, diagnosis and treatment.
Judicial principles:
The court referred to paragraph 48 of the Supreme Court Plenum Resolution No. 33 of 15 November 2022, concerning the application of rules on compensation for moral damage.
It emphasised the importance of examining:
Whether the patient received timely and qualified examination.
Whether medical procedures complied with applicable standards.
Whether defects affected diagnosis or treatment.
Whether the defects contributed to deterioration or an adverse outcome.
Whether the medical organisation could establish grounds for exemption from liability.
Relevance to RPM:
Suppose a hospital receives repeated abnormal heart-rate alerts from a patient's registered monitoring device but fails to arrange an appropriate examination.
The principles in this decision may be relevant when evaluating whether the hospital took all necessary and possible measures to provide timely and qualified medical assistance.
The decision is not an RPM-specific judgment; its importance lies in its general medical-negligence principles.
ГАРАНТ
9. AI-based remote monitoring and biotechnology regulation
AI-based RPM systems can analyse large quantities of physiological information and identify possible health risks.
Examples include:
Predicting cardiac abnormalities.
Identifying unusual blood-glucose patterns.
Detecting respiratory deterioration.
Analysing neurological signals.
Predicting complications following regenerative medicine procedures.
Russian regulation must distinguish between three activities:
| Activity | Legal issue |
|---|---|
| Collecting physiological data | Personal-data and medical-device requirements |
| Analysing data through AI | Medical-software registration and safety requirements |
| Making clinical decisions | Medical professional responsibility and telemedicine requirements |
A biotechnology company must not assume that describing its software as an informational platform removes medical-device obligations.
Order No. 193n of 2025 is particularly relevant because it recognises the use of registered AI-based medical-device decision-support systems in certain telemedicine consultations.
ГАРАНТ+1
10. Experimental legal regimes and digital healthcare innovation
Federal Law No. 258-FZ of 31 July 2020 allows Russia to establish experimental legal regimes for digital innovation.
These regimes can permit selected organisations to test new healthcare technologies under specifically approved conditions.
One important example is Government Resolution No. 1164 of 18 July 2023, establishing an experimental legal regime involving medical activities, telemedicine and technologies for collecting and processing information about citizens' health and diagnoses.
The experimental framework is significant because Article 36.2 permits certain statutory requirements to be modified or excluded for participating private healthcare organisations, within the approved programme.
Potential areas of experimentation include:
Remote diagnosis and monitoring.
Digital medical consultations.
Automated analysis of health information.
AI-supported treatment recommendations.
Remote monitoring of chronic diseases.
However, an experimental legal regime is not a general exemption for all Russian healthcare organisations. Its exceptions apply only within the scope and conditions of the approved programme.
RUDN Scientific Journals+1
11. Medical insurance and reimbursement
Remote patient monitoring also creates questions concerning healthcare financing.
Relevant issues include:
Whether remote monitoring is included in the applicable healthcare programme.
Whether the service is covered by compulsory medical insurance (OMS).
Whether private medical insurance covers wearable monitoring.
Whether hospitals can receive reimbursement for remote monitoring services.
Whether medical devices and digital monitoring platforms are separately reimbursable.
The distinction between a medical consultation and continuous monitoring is important.
A monitoring platform may collect data continuously, but that does not automatically mean that every data transmission qualifies as a separately reimbursable medical service.
12. Major legal challenges
| Legal challenge | Potential consequence |
|---|---|
| Inaccurate sensor readings | Incorrect clinical decisions |
| AI algorithmic errors | Diagnostic and treatment risks |
| Cybersecurity breaches | Disclosure of medical information |
| Unauthorised data sharing | Personal-data violations |
| Failure to respond to alerts | Potential medical negligence |
| Unregistered medical software | Regulatory enforcement |
| Unclear contractual responsibility | Disputes between hospitals and technology providers |
| Cross-border data transfers | Data-protection compliance problems |
| Inadequate patient consent | Legal disputes over data processing and treatment |
| Device malfunction | Product and medical-service liability |
13. Practical compliance framework for biotechnology companies
A biotechnology company operating an RPM platform in Russia should establish the following compliance measures.
Remote patient monitoring compliance checklist
Regulatory classification: Determine whether the device or software qualifies as a medical device.
Medical licensing: Obtain the appropriate medical licence if providing regulated medical services.
Physician supervision: Establish a treating-physician-led monitoring process in accordance with Article 36.2.
Patient consent: Establish appropriate consent and lawful grounds for health-data processing.
Data security: Implement access controls, encryption and cybersecurity procedures.
Medical records: Maintain legally compliant electronic documentation and electronic signatures.
Emergency escalation: Establish procedures for responding to critical monitoring alerts.
AI validation: Verify the safety and regulatory status of AI medical software.
Liability allocation: Define the respective responsibilities of doctors, hospitals, software developers and device manufacturers.
Regulatory monitoring: Review changes in Russian healthcare and data-protection legislation.
14. Critical legal analysis
The Russian approach to remote patient monitoring reflects a physician-supervised model of digital healthcare.
Article 36.2 provides the statutory foundation for remote observation, but it does not establish unrestricted authority for technology companies to diagnose and treat patients independently.
Three legal tensions are particularly significant.
First: technological innovation versus medical supervision.
Continuous monitoring technologies can identify health risks earlier than conventional appointments. However, the legal framework retains an important role for the treating physician, particularly when prescribing remote monitoring and modifying treatment.
Second: digital healthcare versus privacy.
RPM systems generate continuous and potentially highly revealing health information. Their operators must reconcile technological efficiency with medical confidentiality, personal-data protection and cybersecurity.
Third: automated decision-making versus professional accountability.
AI systems may identify abnormalities, but their outputs do not automatically replace professional medical judgment. Responsibility must be assessed according to the roles and legal duties of the healthcare organisation, physician, device manufacturer and software provider.
15. Conclusion
Biotechnology Remote Patient Monitoring Law in Russia is principally based on Federal Law No. 323-FZ, particularly Article 36.2, supported by Federal Law No. 152-FZ, medical-device legislation, electronic-documentation requirements and the 2025 telemedicine procedure under Ministry of Health Order No. 193n.
The legal framework recognises remote observation through medical devices and healthcare information systems, subject to physician supervision and applicable procedural safeguards.
Russian courts have begun addressing telemedicine disputes, while general medical-liability decisions provide additional principles for assessing inadequate monitoring, failure to respond to medical information and patient harm.
The central legal principle is that digital monitoring does not eliminate the duty to provide safe, timely and professionally supervised medical care.
16. Important legal references and research sources
Federal Law No. 323-FZ – Article 36.2.
Ministry of Health Order No. 193n of 11 April 2025.
Federal Law No. 152-FZ – Personal Data Protection.
Roszdravnadzor – Medical Device Registration.
Ninth Cassation Court – Case No. 8Г-12682/2024.
Eighth Cassation Court – Case No. 8Г-14517/2026.
Legal Regulation of Telemedicine in Russia – RUDN University Law Journal.
Academic note: This is a research-oriented explanation of Russian law as at November 2026, not a substitute for checking the authoritative consolidated legislation and full court judgments before relying on them in litigation or regulatory submissions.

comments